Exelixis (EXEL) Enterprise Value Growth (5y) (2015 - 2026)
Exelixis (EXEL) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Exelixis |
13.72 Bn |
12.95 Bn |
590.86 Mn |
| Date | Value |
|---|
| Apr 3, 2026 |
8.10% |
| Jan 2, 2026 |
2.57% |
| Oct 3, 2025 |
3.61% |
| Jul 4, 2025 |
8.19% |
| Apr 4, 2025 |
-1.56% |
| Jan 3, 2025 |
-5.45% |
| Sep 27, 2024 |
-9.35% |
| Jun 28, 2024 |
-4.04% |
| Mar 29, 2024 |
-3.79% |
| Dec 29, 2023 |
-7.50% |
| Sep 29, 2023 |
-25.52% |
| Jun 30, 2023 |
-38.46% |
| Mar 31, 2023 |
-41.34% |
| Dec 30, 2022 |
-48.10% |
| Sep 30, 2022 |
-59.61% |
| Jul 1, 2022 |
-62.56% |
| Apr 1, 2022 |
-53.68% |
| Dec 31, 2021 |
-57.44% |
| Oct 1, 2021 |
-34.42% |
| Jul 2, 2021 |
-32.63% |
